Range Low Price High Price Comment
30 days $39.95 $39.95 Monday, 9th Oct 2023 ISEE stock ended at $39.95. During the day the stock fluctuated 0% from a day low at $39.95 to a day high of $39.95.
90 days $39.95 $39.95
52 weeks $16.67 $39.99

Historical IVERIC bio Inc. prices

Date Open High Low Close Volume
Oct 09, 2023 $39.95 $39.95 $39.95 $39.95 0
Oct 06, 2023 $39.95 $39.95 $39.95 $39.95 0
Oct 05, 2023 $39.95 $39.95 $39.95 $39.95 0
Oct 04, 2023 $39.95 $39.95 $39.95 $39.95 0
Oct 03, 2023 $39.95 $39.95 $39.95 $39.95 0
Oct 02, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 29, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 28, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 27, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 26, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 25, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 22, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 20, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 19, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 18, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 15, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 14, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 13, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 12, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 11, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 08, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 07, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 06, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 05, 2023 $39.95 $39.95 $39.95 $39.95 0
Sep 01, 2023 $39.95 $39.95 $39.95 $39.95 0
Click to get the best stock tips daily for free!

About IVERIC bio Inc.

IVERIC bio. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degenera... ISEE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT